US Stock MarketDetailed Quotes

Arcutis Biotherapeutics (ARQT)

Watchlist
  • 24.530
  • +0.340+1.41%
Close Apr 17 16:00 ET
  • 24.530
  • 0.0000.00%
Post 20:01 ET
3.04BMarket Cap-188.69P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arcutis Biotherapeutics (ARQT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
91.34%376.07M
81.48%129.5M
121.69%99.22M
164.13%81.5M
32.84%65.85M
229.74%196.54M
427.58%71.36M
17.44%44.76M
494.57%30.86M
1,682.42%49.57M
Operating revenue
123.41%372.07M
83.83%127.5M
121.69%99.22M
164.13%81.5M
196.01%63.85M
470.62%166.54M
412.79%69.36M
451.92%44.76M
546.92%30.86M
675.58%21.57M
Cost of revenue
91.84%36.7M
69.27%11.69M
57.82%8.69M
116.28%7.49M
171.19%8.83M
283.56%19.13M
207.44%6.91M
365.57%5.5M
346.39%3.46M
315.84%3.26M
Gross profit
91.29%339.38M
82.79%117.82M
130.65%90.53M
170.18%74.01M
23.11%57.02M
224.82%177.41M
471.41%64.46M
6.30%39.25M
520.62%27.39M
2,217.97%46.31M
Operating expense
14.97%351.6M
37.93%99.43M
4.71%82.01M
14.40%88.62M
4.63%81.55M
3.41%305.81M
-0.50%72.09M
6.08%78.32M
8.84%77.47M
-0.42%77.94M
Selling and administrative expenses
19.69%274.55M
37.10%78.98M
6.10%62.4M
18.90%69.17M
16.80%64M
23.90%229.39M
18.35%57.61M
23.58%58.82M
26.58%58.17M
27.67%54.79M
Research and development costs
0.83%77.05M
41.24%20.45M
0.53%19.6M
0.80%19.45M
-24.19%17.54M
-30.89%76.42M
-39.10%14.48M
-25.67%19.5M
-23.48%19.3M
-34.53%23.14M
Operating profit
90.48%-12.23M
340.92%18.39M
121.82%8.53M
70.82%-14.61M
22.43%-24.53M
46.75%-128.4M
87.52%-7.63M
-5.86%-39.07M
24.99%-50.08M
58.54%-31.62M
Net non-operating interest income expense
71.15%-3.19M
-44.25%5.9M
53.84%-3.07M
59.53%-3.03M
60.13%-2.98M
35.78%-11.04M
122.40%10.58M
11.99%-6.65M
-1.84%-7.48M
-6.22%-7.48M
Non-operating interest income
-44.83%8.9M
----
----
----
----
28.83%16.13M
----
----
----
----
Non-operating interest expense
-55.52%12.08M
-45.94%3M
-53.84%3.07M
-59.53%3.03M
-60.13%2.98M
-8.56%27.17M
-28.48%5.55M
-11.99%6.65M
1.84%7.48M
6.22%7.48M
Other net income (expense)
842.55%443K
52.13%-6.42M
-51.34%2.04M
-59.92%2.1M
-32.49%2.73M
106.43%47K
-36.19%-13.41M
53.69%4.18M
67.54%5.23M
26.10%4.04M
Other non- operating income (expenses)
842.55%443K
52.13%-6.42M
-51.34%2.04M
-59.92%2.1M
-32.49%2.73M
106.43%47K
-36.19%-13.41M
53.69%4.18M
67.54%5.23M
26.10%4.04M
Income before tax
89.26%-14.97M
270.71%17.87M
118.03%7.49M
70.30%-15.54M
29.31%-24.78M
46.19%-139.39M
84.21%-10.47M
0.49%-41.54M
26.28%-52.33M
56.23%-35.06M
Income tax
80.99%1.17M
45.51%470K
80K
342K
-13.89%279K
-79.22%647K
1,192.00%323K
0
0
324K
Net income
88.47%-16.14M
261.24%17.4M
117.84%7.41M
69.64%-15.89M
29.17%-25.06M
46.58%-140.04M
83.72%-10.79M
7.21%-41.54M
26.28%-52.33M
55.83%-35.38M
Net income continuous Operations
88.47%-16.14M
261.24%17.4M
117.84%7.41M
69.64%-15.89M
29.17%-25.06M
46.58%-140.04M
83.72%-10.79M
7.21%-41.54M
26.28%-52.33M
55.83%-35.38M
Minority interest income
Net income attributable to the parent company
88.47%-16.14M
261.24%17.4M
117.84%7.41M
69.64%-15.89M
29.17%-25.06M
46.58%-140.04M
83.72%-10.79M
7.21%-41.54M
26.28%-52.33M
55.83%-35.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
88.47%-16.14M
261.24%17.4M
117.84%7.41M
69.64%-15.89M
29.17%-25.06M
46.58%-140.04M
83.72%-10.79M
7.21%-41.54M
26.28%-52.33M
55.83%-35.38M
Basic earnings per share
88.79%-0.13
255.56%0.14
118.18%0.06
69.05%-0.13
37.50%-0.2
69.31%-1.16
87.50%-0.09
54.79%-0.33
63.79%-0.42
75.57%-0.32
Diluted earnings per share
88.79%-0.13
244.44%0.13
116.69%0.0558
69.05%-0.13
37.50%-0.2
69.31%-1.16
87.50%-0.09
54.22%-0.3342
63.79%-0.42
75.57%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 91.34%376.07M81.48%129.5M121.69%99.22M164.13%81.5M32.84%65.85M229.74%196.54M427.58%71.36M17.44%44.76M494.57%30.86M1,682.42%49.57M
Operating revenue 123.41%372.07M83.83%127.5M121.69%99.22M164.13%81.5M196.01%63.85M470.62%166.54M412.79%69.36M451.92%44.76M546.92%30.86M675.58%21.57M
Cost of revenue 91.84%36.7M69.27%11.69M57.82%8.69M116.28%7.49M171.19%8.83M283.56%19.13M207.44%6.91M365.57%5.5M346.39%3.46M315.84%3.26M
Gross profit 91.29%339.38M82.79%117.82M130.65%90.53M170.18%74.01M23.11%57.02M224.82%177.41M471.41%64.46M6.30%39.25M520.62%27.39M2,217.97%46.31M
Operating expense 14.97%351.6M37.93%99.43M4.71%82.01M14.40%88.62M4.63%81.55M3.41%305.81M-0.50%72.09M6.08%78.32M8.84%77.47M-0.42%77.94M
Selling and administrative expenses 19.69%274.55M37.10%78.98M6.10%62.4M18.90%69.17M16.80%64M23.90%229.39M18.35%57.61M23.58%58.82M26.58%58.17M27.67%54.79M
Research and development costs 0.83%77.05M41.24%20.45M0.53%19.6M0.80%19.45M-24.19%17.54M-30.89%76.42M-39.10%14.48M-25.67%19.5M-23.48%19.3M-34.53%23.14M
Operating profit 90.48%-12.23M340.92%18.39M121.82%8.53M70.82%-14.61M22.43%-24.53M46.75%-128.4M87.52%-7.63M-5.86%-39.07M24.99%-50.08M58.54%-31.62M
Net non-operating interest income expense 71.15%-3.19M-44.25%5.9M53.84%-3.07M59.53%-3.03M60.13%-2.98M35.78%-11.04M122.40%10.58M11.99%-6.65M-1.84%-7.48M-6.22%-7.48M
Non-operating interest income -44.83%8.9M----------------28.83%16.13M----------------
Non-operating interest expense -55.52%12.08M-45.94%3M-53.84%3.07M-59.53%3.03M-60.13%2.98M-8.56%27.17M-28.48%5.55M-11.99%6.65M1.84%7.48M6.22%7.48M
Other net income (expense) 842.55%443K52.13%-6.42M-51.34%2.04M-59.92%2.1M-32.49%2.73M106.43%47K-36.19%-13.41M53.69%4.18M67.54%5.23M26.10%4.04M
Other non- operating income (expenses) 842.55%443K52.13%-6.42M-51.34%2.04M-59.92%2.1M-32.49%2.73M106.43%47K-36.19%-13.41M53.69%4.18M67.54%5.23M26.10%4.04M
Income before tax 89.26%-14.97M270.71%17.87M118.03%7.49M70.30%-15.54M29.31%-24.78M46.19%-139.39M84.21%-10.47M0.49%-41.54M26.28%-52.33M56.23%-35.06M
Income tax 80.99%1.17M45.51%470K80K342K-13.89%279K-79.22%647K1,192.00%323K00324K
Net income 88.47%-16.14M261.24%17.4M117.84%7.41M69.64%-15.89M29.17%-25.06M46.58%-140.04M83.72%-10.79M7.21%-41.54M26.28%-52.33M55.83%-35.38M
Net income continuous Operations 88.47%-16.14M261.24%17.4M117.84%7.41M69.64%-15.89M29.17%-25.06M46.58%-140.04M83.72%-10.79M7.21%-41.54M26.28%-52.33M55.83%-35.38M
Minority interest income
Net income attributable to the parent company 88.47%-16.14M261.24%17.4M117.84%7.41M69.64%-15.89M29.17%-25.06M46.58%-140.04M83.72%-10.79M7.21%-41.54M26.28%-52.33M55.83%-35.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 88.47%-16.14M261.24%17.4M117.84%7.41M69.64%-15.89M29.17%-25.06M46.58%-140.04M83.72%-10.79M7.21%-41.54M26.28%-52.33M55.83%-35.38M
Basic earnings per share 88.79%-0.13255.56%0.14118.18%0.0669.05%-0.1337.50%-0.269.31%-1.1687.50%-0.0954.79%-0.3363.79%-0.4275.57%-0.32
Diluted earnings per share 88.79%-0.13244.44%0.13116.69%0.055869.05%-0.1337.50%-0.269.31%-1.1687.50%-0.0954.22%-0.334263.79%-0.4275.57%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -